E-LIB Suche - Ergebnisse für: Jaeckle, Kurt

1

Clinical features and outcomes in primary nervous system hi..:

Nathoo, Nabeela ; Uhm, Joon H. ; Porter, Alyx B....
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

Case Report: "Aggressive" perioperative antiseizure medicat..:

Freund, Brin E. ; Jaeckle, Kurt ; Quinones-Hinojosa, Alfredo.
Frontiers in Surgery. 10 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

CTNI-03. EFFICACY OF WSD0922-FU IN OSIMERTINIB-RESISTANT NS..:

Kizilbash, Sani H ; Jaeckle, Kurt ; Mrugala, Maciej...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v73-v73 , 2023

Link: https://doi.org/10.1093/..

4

TIPS-09 FIRST-IN-HUMAN PHASE 1 TRIAL OF THE SAFETY, TOLERAB..:

Kizilbash, Sani ; Jaeckle, Kurt ; Mrugala, Maciej...
Neuro-Oncology Advances. 5 (2023) Supplement_3 - p. iii36-iii36 , 2023

Link: https://doi.org/10.1093/..

5

Isocitrate Dehydrogenase Mutant Grade II and III Glial Neop..:

Mellinghoff, Ingo K. ; Chang, Susan M. ; Jaeckle, Kurt A..
Hematology/Oncology Clinics of North America. 36 (2022) 1 - p. 95-111 , 2022

Link: https://doi.org/10.1016/..

6

EXTH-20. IDENTIFICATION OF EX VIVO THERAPEUTIC VULNERABILIT..:

Lin, Wan-Hsin ; Smadbeck, James ; Barrett, Michael...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii213-vii214 , 2022

Link: https://doi.org/10.1093/..

7

Liquid biopsy in gliomas: A RANO review and proposals for c..:

Soffietti, Riccardo ; Bettegowda, Chetan ; Mellinghoff, Ingo K...
Neuro-Oncology. 24 (2022) 6 - p. 855-871 , 2022

Link: https://doi.org/10.1093/..

8

Phase I/randomized phase II trial of TRC105 plus bevacizuma..:

Galanis, Evanthia ; Anderson, S Keith ; Twohy, Erin...
Neuro-Oncology Advances. 4 (2022) 1 - p. , 2022

Link: https://doi.org/10.1093/..

9

NIMG-01. INTEROBSERVER VARIABILITY OF THE REVISED IMAGING S..:

Le Rhun, Emilie ; Devos, Patrick ; Winklhofer, Sebastian...
Neuro-Oncology. 23 (2021) Supplement_6 - p. vi126-vi127 , 2021

Link: https://doi.org/10.1093/..

10

CODEL: phase III study of RT, RT + TMZ, or TMZ for newly di..:

Jaeckle, Kurt A ; Ballman, Karla V ; van den Bent, Martin...
Neuro-Oncology. 23 (2020) 3 - p. 457-467 , 2020

Link: https://doi.org/10.1093/..

11

CTNI-29. CODEL: PHASE III TRIAL OF RT ALONE, RT PLUS TMZ, O..:

Jaeckle, Kurt ; Ballman, Karla ; van den Bent, Martin...
Neuro-Oncology. 22 (2020) Supplement_2 - p. ii48-ii49 , 2020

Link: https://doi.org/10.1093/..

12

Intra‐CSF topotecan in treatment of breast cancer patients ..:

Jaeckle, Kurt A. ; Dixon, Jesse G. ; Anderson, Stephen Keith...
Cancer Medicine. 9 (2020) 21 - p. 7935-7942 , 2020

Link: https://doi.org/10.1002/..

13

Correction to: Phase I-II trial of imatinib mesylate (Gleev..:

Jaeckle, Kurt A. ; Anderson, S. K. ; Twohy, Erin L....
Journal of Neuro-Oncology. 143 (2019) 3 - p. 583-583 , 2019

Link: https://doi.org/10.1007/..

14

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in ..:

Jaeckle, Kurt A. ; Anderson, S. K. ; Twohy, Erin L....
Journal of Neuro-Oncology. 143 (2019) 3 - p. 573-581 , 2019

Link: https://doi.org/10.1007/..

15

Examiner accuracy in cognitive testing in multisite brain-t..:

Cerhan, Jane H ; Anderson, S Keith ; Butts, Alissa M...
Neuro-Oncology Practice. 6 (2018) 4 - p. 283-288 , 2018

Link: https://doi.org/10.1093/..